Skip to search.
 STI Down0.04%

Merck & Co., Inc. (MRK)

-NYQ
63.01 30 Aug 04:00 SGT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending31 Dec, 201531 Dec, 201431 Dec, 2013
Net Income 4,442,000   11,920,000   4,404,000  
Operating Activities, Cash Flows Provided By or Used In
Depreciation6,375,000  6,691,000  6,988,000  
Adjustments To Net Income1,855,000  (12,589,000)943,000  
Changes In Accounts Receivables(480,000)(554,000)436,000  
Changes In Liabilities(588,000)2,397,000  (1,428,000)
Changes In Inventories805,000  79,000  (365,000)
Changes In Other Operating Activities(5,000)(98,000)563,000  
Total Cash Flow From Operating Activities 12,421,000   7,860,000   11,654,000  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(1,283,000)(1,317,000)(1,548,000)
Investments3,871,000  (9,635,000)(1,343,000)
Other Cash flows from Investing Activities(7,346,000)10,578,000  (257,000)
Total Cash Flows From Investing Activities (4,758,000) (374,000) (3,148,000)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid(5,117,000)(5,170,000)(5,157,000)
Sale Purchase of Stock(3,701,000)(6,220,000)(5,426,000)
Net Borrowings3,492,000  (3,931,000)4,533,000  
Other Cash Flows from Financing Activities56,000  208,000  60,000  
Total Cash Flows From Financing Activities (5,270,000) (15,113,000) (5,990,000)
Effect Of Exchange Rate Changes(1,310,000)(553,000)(346,000)
Change In Cash and Cash Equivalents 1,083,000   (8,180,000) 2,170,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.